IpsenIPSEF 95 Median PS Value is $95.72 as of Jun. 24, 2026, which is 10655% above its 10-year median of 0.89. GuruFocus rates IPSEF with a GF Score™ of 95/100 and a GF Value™ of $92.81. The stock has 7 warning signs investors should review. Among 544 Drug Manufacturers companies, Ipsen ranks worse than 71.51% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Ipsen's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $54.777. Ipsen's 10-Year median PS Ratio is 1.7474. Therefore, the Median PS Value for today is $95.72.
As of today (2026-06-24), Ipsen's share price is $113.13. Ipsen's Median PS Value is $95.72. Therefore, Ipsen's Price to Median PS Value for today is 1.18.
The historical rank and industry rank for Ipsen's Median PS Value or its related term are showing as below:
IPSEF'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.77 Med: 0.89 Max: 1.61
Current: 1.18
During the past 13 years, the highest Price to Median PS Value of Ipsen was 1.61. The lowest was 0.77. And the median was 0.89.
IPSEF's Price-to-Median-PS-Value is ranked worse than 71.51% of 544
companies
in the Drug Manufacturers industry
Industry Median: 0.85
vs IPSEF: 1.18
Ipsen (OTCPK:IPSEF) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Ipsen's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
113.13
/
95.72
=
1.18
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipsen Median PS Value Related Terms
Ipsen Median PS Value Historical Data
* Premium members only.
The historical data trend for Ipsen's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPSEF vs ZTS, UTHR, VTRS: Median PS Value Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ipsen's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ipsen Price-to-Median-PS-Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ipsen's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Ipsen's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.7474.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ipsen's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $54.777.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipsen (IPSEF) has a Median PS Value of $95.72 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Ipsen and its competitors. This is 10655% above median its historical median of 0.89. Over the past decade, Ipsen's Median PS Value has ranged from 0.77 to 1.61. According to the industry distribution chart, Ipsen ranks #389 out of 544 companies in the Drug Manufacturers industry, placing it in the top 71.5%.
Is Ipsen's Median PS Value too high?
Ipsen's current Median PS Value of $95.72 is 10655% above median its 10-year median of 0.89. Over the past 10 years, this metric has ranged from a low of 0.77 to a high of 1.61. The Drug Manufacturers industry median Median PS Value is 0.85. Ipsen's value of $95.72 is 11161.2% above this industry median. Based on the distribution chart, Ipsen ranks #389 out of 544 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Ipsen has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does Ipsen's Median PS Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ipsen ranks #389 out of 544 companies for Median PS Value. This places Ipsen in the lower half of its industry. The industry median Median PS Value is 0.85. Ipsen's value of $95.72 is 11161.2% above this benchmark. Historically, Ipsen's own Median PS Value has ranged from 0.77 to 1.61 over the past decade. While the company's 10-year median is 0.89 vs. the industry median of 0.85, Ipsen has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Drug Manufacturers company?
The median Median PS Value among Drug Manufacturers companies is 0.85, based on 544 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ipsen's current Median PS Value of $95.72 is 11161.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Ipsen and its competitors. For the Drug Manufacturers industry, the median Median PS Value is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ipsen's current Median PS Value is $95.72, which is 10655% above median its own 10-year median of 0.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ipsen stock overvalued right now?
Ipsen (IPSEF) has a current Median PS Value of $95.72. The stock's GF Value™ is $92.81, compared to a current price of $113.13 — trading 21.9% above its estimated fair value. The current Median PS Value is $95.72, which is 10655% above median its 10-year median of 0.89 and 11161.2% above the Drug Manufacturers industry median of 0.85. Ipsen's overall GF Score™ is 95/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Ipsen (IPSEF), the current Median PS Value is $95.72 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ipsen (IPSEF) Overvalued in 2026?
Based on GuruFocus' analysis, Ipsen stock appears to be overvalued.
The current stock price of $113.13 is trading 21.9% above its estimated GF Value™ of $92.81.
Key valuation signals for IPSEF:
Median PS Value: $95.72 (10655% above median its 10-year median of 0.89)
GF Value™: $92.81 vs. price of $113.13 (21.9% above fair value)
Industry Position: 11161.2% above the Drug Manufacturers median (#389 of 544)
No single metric tells the full story. See the IPSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders, but in February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for only 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 20 drugs in 115 countries.
95GF Score
Get the complete analysis for IPSEF
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IPSEF has been successfully added to your 
